In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1664 News Items found
In the Clinic
MSK patient Michael Szczerbienski
New Combination Drug Treatment Helps Some People With Stage 4 Kidney Cancer

An international phase 3 clinical trial has shown that adding a targeted therapy to a standard combination for stage 4 kidney cancer is more effective than giving the standard treatment alone, although the new combination has significant side effects.
A microscope image of a mouse embryo
The Right Moves: How Studying Cell Movement During Embryonic Development May Offer New Insights Into Cancer Metastasis

New insights into the way cells break away from a tissue during embryonic development may also shed new light on the same process in the context of cancer metastasis.
Feature
Dr. Prasad Adusumilli sits at a computer. A patient’s face and a chest image are on the screen.
Getting a Second Opinion After a Cancer Diagnosis: 9 Things To Know

Whether you’ve been diagnosed with a rare cancer or one that’s more common, MSK doctors can provide a second opinion.
MSK medical oncologist and breast cancer specialist Sarat Chandarlapaty.
MSK Discovery of ESR1 Gene Mutation Leads to Approval of Breast Cancer Drug Elacestrant

Learn how an MSK lab discovery in 2013 paved the way for the approval of a new breast cancer drug 10 years later.
See Dr. Kojo Elenitoba-Johnson, the inaugural Chair of the MSK Department of Pathology and Laboratory Medicine.
Pinpoint Accuracy: How Dr. Elenitoba-Johnson Helps Lead the Diagnosis of Cancer at MSK

Learn about Dr. Kojo Elenitoba-Johnson, who leads teams of Memorial Sloan Kettering experts in interpreting lab tests and diagnosing cancer as the inaugural Chair of the MSK Department of Pathology and Laboratory Medicine. He is also a member in the Human Oncology and Pathogenesis Program.
An MSK scientist peers through a microscope
MSK Research Highlights, April 21, 2023

New MSK research finds adherence is a hurdle for home-based colorectal cancer tests; sheds new light on tumor-associated macrophages in glioblastoma; identifies statins as a promising addition to treatment for HER2-positive gastric cancer; and describes how a new single-cell transcriptome atlas opens the “black box” of early human embryo development.
Marie-Josée Kravis Quantitative Biology Fellows Corey Weistuch and Sneha Mitra
Quantitative Biology Fellowship Targets Cancer With Math and Computer Science

Learn about the Marie-Josée Kravis Fellowship in Quantitative Biology, a two-year postdoctoral fellowship that aims to build a new generation of skilled quantitative biologists who specialize in cancer.
Finding
Gloved hands hold a pipette over two bottles of pink solution.
The Gut Microbiome and Cancer: MSK Researchers Present New Findings

Research led by Josie Robertson Investigator Karuna Ganesh provided clues that microbiomes might explain the increase in colorectal cancer among younger patients.
MSK computational biologist Henry Walch
Why Is Colorectal Cancer in African Americans Hard To Treat? One Reason Is Genetics

African American patients with colorectal cancer are less likely to have tumors that respond well to newer treatments such as targeted therapy and immunotherapy.
MSK medical oncologist and bladder cancer specialist Jonathan Rosenberg
New Metastatic Bladder Cancer Therapy Approved by FDA: Enfortumab Vedotin (Padcev)

A powerful therapy called an antibody-drug conjugate is approved for more people with metastatic bladder cancer.